Top managers continue to focus on higher-quality dividend-paying stocks in a fully valued market.
Roche purchases shares in tender offer for InterMune, Inc.
Genentech’s Perjeta Regimen Extended the Lives of People With an Aggressive Type of Metastatic Breast Cancer by 15.7 Months Compared to Herceptin and Chemotherapy
Roche launches Global Access Program for HIV viral load testing
While more than one third of these top fund managers are outperforming this year, four of them stand out from the rest given their ability to outperform the market over almost all time periods.
More than a dozen analyst-approved foreign large-cap funds own these names.
While a majority of our top fund managers are outperforming this year, five of them truly stand out from the rest given their ability to outperform the market over all time periods.
This year's list contains the 1998 and 2008 winners of the award.
Brand recognition and product innovation keep the firm's moat wide.
This fund's comeback from the financial crisis has been balky, but it still has promise.